Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Sex-related differences in heart failure and beta-blockers.

Literature DB >> 15516863

Sex-related differences in heart failure and beta-blockers.

Abstract

Under-representation of women in heart failure trials has limited our knowledge of heart failure in women to extrapolation of findings from men. Significant sex related differences in clinical and laboratory characteristics exist in systolic heart failure including better survival in women. The value of various therapeutic interventions should be based on proven effect in women and not on an assumption based on proven benefit in men. Among the medications currently recommended for patients with systolic heart failure, beta-blockers have the strongest data supporting their efficacy in women.

Entities: Disease Species

Mesh：

Substances：

Year: 2004 PMID： 15516863 DOI： 10.1023/B:HREV.0000046370.81174.94

Source DB: PubMed Journal: Heart Fail Rev ISSN： 1382-4147 Impact factor: 4.214

64 in total

1. A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure.

Authors: Eric J Eichhorn; Michael J Domanski; Heidi Krause-Steinrauf; Michael R Bristow; Philip W Lavori
Journal: N Engl J Med Date: 2001-05-31 Impact factor: 91.245

2. Estrogen is associated with improved survival in aging women with congestive heart failure: analysis of the vesnarinone studies.

Authors: S E Reis; R Holubkov; J B Young; B G White; J N Cohn; A M Feldman
Journal: J Am Coll Cardiol Date: 2000-08 Impact factor: 24.094

3. Effect of long-term hormone replacement therapy on angiotensin-converting enzyme activity and bradykinin in postmenopausal women with essential hypertension and normotensive postmenopausal women.

Authors: N Nogawa; H Sumino; S Ichikawa; H Kumakura; Y Takayama; T Nakamura; T Kanda; H Mizunuma; M Kurabayashi
Journal: Menopause Date: 2001 May-Jun Impact factor: 2.953

4. Gender-related effects on metoprolol pharmacokinetics and pharmacodynamics in healthy volunteers.

Authors: A B Luzier; A Killian; J H Wilton; M F Wilson; A Forrest; D J Kazierad
Journal: Clin Pharmacol Ther Date: 1999-12 Impact factor: 6.875

5. Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators.

Authors: J R Hampton; D J van Veldhuisen; F X Kleber; A J Cowley; A Ardia; P Block; A Cortina; L Cserhalmi; F Follath; G Jensen; J Kayanakis; K I Lie; G Mancia; A M Skene
Journal: Lancet Date: 1997-04-05 Impact factor: 79.321

6. A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors: R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal: Am Heart J Date: 1997-07 Impact factor: 4.749

7. Gender-related differences in myocyte remodeling in progression to heart failure.

Authors: T Tamura; S Said; A M Gerdes
Journal: Hypertension Date: 1999-02 Impact factor: 10.190

8. Postmenopausal hormonal replacement decreases plasma levels of endothelin-1.

Authors: O Ylikorkala; A Orpana; J Puolakka; T Pyörälä; L Viinikka
Journal: J Clin Endocrinol Metab Date: 1995-11 Impact factor: 5.958

9. Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors: M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal: N Engl J Med Date: 1996-10-10 Impact factor: 91.245

3. Factors associated with poor prognosis among patients admitted with heart failure in a Nigerian tertiary medical centre: a cross-sectional study.

Authors: Kamilu M Karaye; Mahmoud U Sani
Journal: BMC Cardiovasc Disord Date: 2008-07-22 Impact factor: 2.298

3 in total